PPAR is a nuclear receptor involved in fat oxidation, energy expenditure, and mitochondrial function
However, some factors that can contribute to the development of this condition include: Diabetes (the most common known cause) Surgical injury to the vagus nerve Certain medications (e.g., narcotics, antidepressants) Viral stomach infections Neurological disorders (e.g., Parkinson's disease, multiple sclerosis) Hypothyroidism Rare conditions (e.g., amyloidosis, scleroderma) To diagnose gastroparesis, your doctor will review your symptoms, medical history, and perform a physical examination
8.5 Geriatric Use Population pharmacokinetic analysis of patients ranging from 22 to 73 years of age suggests that age does not influence the pharmacokinetic properties of exenatide [see Clinical Pharmacology (12.3)]
Insoluble material was removed by centrifugation at 40,000 g for 30 min, and the supernatant was incubated with HPC4 resin and 5 mM CaCl 2 overnight at 4 C
Research on FDA-approved GLP-1 drugs is often cited in this category, but consumers should not assume compounded products are evaluated in the same way as FDA-approved finished medications